| Title | Prospective Grant of an Exclusive Patent License: The Development of an in vivo Anti-CD19 Chimeric Antigen Receptor for the Treatment of CD19-Expressing Human Cancers |
| ToC Doc | The Development of an in vivo Anti-CD19 Chimeric Antigen Receptor for the Treatment of CD19-Expressing Human Cancers |
| Docket Number | 2022-16056 |
| Type | Notice |
| Subject | Prospective Grant of an Exclusive Patent License: The Development of an in vivo Anti-CD19 Chimeric Antigen Receptor for the Treatment of CD19-Expressing Human Cancers |
| Publication Date | 2022-07-27 |
| Last Updated Date | 2022-07-26 08:15:08 -0400 |
| Last Public Inspection | 2022-07-26 |
| Filed At | 2022-07-26T08:45:00.000-04:00 |
| 2022-16056_PI.pdf (104955 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 4 |
| Filing Type | regular |
| Agencies | National Institutes of Health |
You can find the raw source document below...